There have long been suggestions that men already diagnosed with and receiving treatment for diabetes are at lower risk for a subsequent diagnosis of prostate cancer than non-diabetics. However, a very large, new, epidemiological analysis seems to suggest strongly that this may not be the case at all. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: ant-diabetic, diabetes, medication, Prevention, risk | 3 Comments »
To quote Howard himself, “Not much on PC, but FYI.” But on the other hand, it is very much about the sometimes challenging aspects of “being a patient” — prostate cancer included. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: diabetes, journey, metformin, patient, Wolinksy | 5 Comments »
… and it’s one that is not exactly uncommon for older men (with or without prostate cancer). … To get the scoop, just click here. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, diabetes, Wolinsky | 1 Comment »
There have been suggestions for some time (but no confirmation yet from large scale clinical trials) that treatment with the antidiabetic agent metformin may be beneficial in the management of at least some forms of prostate cancer. However, … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: antidiabetic, diabetes, metformin | 1 Comment »
A retrospective analysis of data from > 3,800 Canadian men has suggested that diabetic men who also had prostate cancer and were being treated with a commonly used, generic drug called metformin have a reduced risk for death from prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, metformin, survival | 1 Comment »
A new paper recently published on line in Urology (“the Gold Journal”) suggests that men with diabetes who are treated with curative intent for localized prostate cancer using external beam radiation therapy may experience higher than normal risk for late genitourinary complications and adverse effects. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diabetes, external beam, localized, radiation | Leave a comment »
It has long been understood that treatment of prostate cancer with androgen deprivation therapy (ADT) can both increase the risk for diabetes among non-diabetic patients and can decrease sensitivity to insulin among men with diabetes. What has been missing, however, are good data about how ADT affects diabetes control among men with diabetes. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation, diabetes, HbA1c | 1 Comment »
We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: allele, diabetes, genetics, genome, risk | Leave a comment »
It has long been recognized that the combination of prostate cancer and diabetes tends to have a notable impact on the health-related quality of life (HRQoL) of male patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, HRQOL, quality of life | Leave a comment »
Today’s news reports address:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diabetes, endorectal coil, erectile dysfunction, MRI, penile rehabilitation, radiotherapy, risk | Leave a comment »
In this weekend’s prostate cancer news reports, we have addressed recent publications on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a comment »
Today’s news reports deal with:
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, diabetes, dutasteride, magmentic resonance spectroscopic imaging, MSRI, REDEEM, risk | Leave a comment »
A recently published study has suggested the possibility of an association between the aggressiveness of prostate cancer and degree of glycemic control in some patients with an existing diagnosis of diabetes. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: aggressiveness, diabetes, glycemic control, HbA1c | Leave a comment »
As reported by Reuters Health earlier today, the majority of men with early-stage, low- or moderate-grade prostate cancer do not, in fact die from this disease. This topic has been carefully addressed by a recent article in the January issue of the Journal of the American Geriatric Society. Prevention and management of other health conditions is a critical factor in the health care management of these patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: cardiovascular risk, diabetes, mortality, obesity, survival | Leave a comment »
Today being December 31, this will be the final daily news report of the first calendar year of existence for The “New” Prostate Cancer InfoLink.
There are three reports covered in the news below, the most important of which supports the idea that men with diabetes have a reduced risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk, Treatment | Tagged: conformal arc, diabetes, genes, image-guided, radiotherapy | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 